Home > News > November AG Announcement
September 22nd, 2005
November AG Announcement
Abstract:
The Erlangen based bio- and nanotechnology holding company, november AG, will immediately continue the development of its analyzer for the complete system of rapid and laboratory independent nucleic acid diagnostics, the primary project of its subsidiary directif GmbH, together with GBN Systems GmbH. This is facilitated through contractual changes in cooperation with Siemens AG, the previous strategic partner in the development of the analyzer.
Source:
vwd.de
Related Links |
Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||